Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Apatinib in Maintenance Treatment of Extensive-stage Small-cell Lung Cancer

NCT03129698 is registered in ClinicalTrials.gov with Junling Li as lead sponsor.

NCT NCT03129698
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03129698 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Apatinib in Maintenance Treatment of Extensive-stage Small-cell Lung Cancer
Lead sponsor
Junling Li
Phase
Phase 2
Overall status
Unknown status
Start date
April 11, 2017
Completion date
March 1, 2020
Enrollment
52 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

apatinib in maintenance treatment